Close

Ratings by Cantor Fitzgerald

Date Analyst CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/29/2023 Charles Duncan Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
87.00
(83.00)
 
 
  Details
3/28/2023 Pete Stavropoulos Orchard Therapeutics ORTX Maintain Overweight
(N/A)
15.00
(3.00)
 
 
  Details
3,547 more...